(in millions $) | 31 Dec 2021 | 30 Sep 2021 | 30 Jul 2021 | 31 Mar 2021 |
---|---|---|---|---|
Current assets | ||||
Cash | $43874 | $49320 | $26096 | $23973.64 |
Short term investments | $17988 | $17251 | $15169 | $27564.1 |
Net receivables | $2946 | $5457 | $10353 | $7815.22 |
Inventory | $197.96 | $247.16 | ||
Total current assets | $68766 | $77035 | $56054 | $63609.92 |
Long term investments | $23356 | $11271 | $28422 | $24452.21 |
Property, plant & equipment | $9288 | $9762 | $12063 | $10923.24 |
Goodwill & intangible assets | $49664 | $52822 | $53695 | |
Total noncurrent assets | $84232 | $78796 | $94501.07 | |
Total investments | $41344 | $28522 | $52016.31 | |
Total assets | $152998 | $155831 | $155272 | $158110.99 |
Current liabilities | ||||
Accounts payable | $4874 | $5175 | $4589 | $4643.47 |
Deferred revenue | $546 | $711 | $885.39 | |
Short long term debt | $7355 | $7893 | $8274.36 | |
Total current liabilities | $24423 | $26553 | $24564 | $23019.72 |
Long term debt | $2336 | $2701 | $2383 | $2715.51 |
Total noncurrent liabilities | $3128 | $3563 | $3654.03 | |
Total debt | $9691 | $10594 | $10989.87 | |
Total liabilities | $27551 | $30116 | $41607 | $26673.75 |
Shareholders' equity | ||||
Retained earnings | -$135765 | -$135578 | -$105181 | -$80926.43 |
Other shareholder equity | -$3601 | -$2448 | -$2698 | -$1577.7 |
Total shareholder equity | $112047 | $112526 | -$76174 | -$69921.76 |
(in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Current assets | ||||
Cash | $43874 | $21609.78 | $12790.79 | $14462.89 |
Short term investments | $17988 | $40275.8 | $41360.21 | $38269.03 |
Net receivables | $2946 | $2540.95 | $6152.94 | $5391.93 |
Inventory | $197.96 | $261.55 | $201.23 | $153.61 |
Total current assets | $68766 | $68681.48 | $62753.61 | $59900.79 |
Long term investments | $23356 | $7698.95 | $14515.86 | $16307.42 |
Property, plant & equipment | $9288 | $11750.75 | $8336.51 | $5778.09 |
Goodwill & intangible assets | $49664 | $54421.57 | ||
Total noncurrent assets | $84232 | $78583.92 | ||
Total investments | $41344 | $47974.75 | ||
Total assets | $152998 | $147265.39 | $144720.53 | $142811.97 |
Current liabilities | ||||
Accounts payable | $4874 | $7634.85 | $3694.19 | $3551.34 |
Deferred revenue | $546 | $915.43 | ||
Short long term debt | $7355 | $6505.43 | ||
Total current liabilities | $24423 | $26359.67 | $14545.42 | $12238.77 |
Long term debt | $2336 | $2624.86 | $765.73 | |
Total noncurrent liabilities | $3128 | $3756.13 | ||
Total debt | $9691 | $9130.29 | ||
Total liabilities | $27551 | $30115.8 | $17739.31 | $14037.85 |
Shareholders' equity | ||||
Retained earnings | -$135765 | -$86411.18 | -$75735.53 | -$65812.47 |
Other shareholder equity | -$3601 | -$2001.2 | $3924.91 | $2503.95 |
Total shareholder equity | $112047 | -$76218.01 | -$62866.02 | -$57503.93 |
(in millions $) | 31 Dec 2021 | 30 Sep 2021 | 30 Jul 2021 | 31 Mar 2021 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $40777 | $42675 | $42163 | |
Cost of revenue | $35921 | $40784 | $37596.73 | |
Gross Profit | $4856 | $1891 | $4566.26 | |
Operating activities | ||||
Research & development | $2466 | $2341 | $1861.9 | |
Selling, general & administrative | $6023 | $6694 | $7209.52 | |
Total operating expenses | $12986 | $10945 | $11220.07 | |
Operating income | -$8130 | -$9054 | -$6653.8 | |
Income from continuing operations | ||||
EBIT | -$50 | -$30203 | $5466.72 | |
Income tax expense | $60 | $112 | -$78.78 | |
Interest expense | $66 | $65 | $60.75 | |
Net income | ||||
Net income | -$176 | -$30380 | $5484.75 | |
Income (for common shares) | -$383 | -$30596 | $195.59 |
(in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $173827 | $141736.15 | $154786.13 | $135288.02 |
Cost of revenue | $156863 | $125824.1 | ||
Gross Profit | $16964 | $15912.05 | $15121.37 | $7445.57 |
Operating activities | ||||
Research & development | $9415 | $6316.8 | ||
Selling, general & administrative | $45677 | $18687.47 | ||
Total operating expenses | $65406 | $29699.99 | $23134.76 | $19888.1 |
Operating income | -$48442 | -$13787.94 | ||
Income from continuing operations | ||||
EBIT | -$48899 | -$10681.35 | ||
Income tax expense | $166 | -$303.2 | -$348.01 | -$513.91 |
Interest expense | $278 | $136.35 | -$462.2 | -$393.52 |
Net income | ||||
Net income | -$49343 | -$10514.5 | -$9728.46 | -$14977.78 |
Income (for common shares) | -$50031 | -$10680.42 |
(in millions $) | 31 Dec 2021 | 30 Sep 2021 | 30 Jul 2021 | 31 Mar 2021 |
---|---|---|---|---|
Net income | -$176 | -$30380 | $5484.75 | |
Operating activities | ||||
Depreciation | $1559.81 | |||
Business acquisitions & disposals | -$13784.61 | |||
Stock-based compensation | $696.98 | |||
Total cash flows from operations | -$1032 | -$5055 | -$6138.21 | |
Investing activities | ||||
Capital expenditures | -$2720.34 | |||
Investments | $15205.43 | |||
Total cash flows from investing | -$2511 | $306 | $3350 | -$2014.35 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $2426.04 | |||
Total cash flows from financing | -$1079 | $27739 | $8531 | $10281.56 |
Effect of exchange rate | -$717 | $50 | $95 | $231.17 |
Change in cash and equivalents | -$5339 | $23040 | $4649 | $2360.16 |
(in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Jan 2020 | 31 Jan 2019 |
---|---|---|---|---|
Net income | -$49343 | -$10514.5 | ||
Operating activities | ||||
Depreciation | $5269.09 | |||
Business acquisitions & disposals | ||||
Stock-based compensation | $3413.29 | |||
Total cash flows from operations | -$13414 | $1137.62 | ||
Investing activities | ||||
Capital expenditures | -$5790.15 | |||
Investments | $4020.6 | |||
Total cash flows from investing | $1145 | -$1946.32 | -$6150.78 | -$18449.45 |
Financing activities | ||||
Dividends paid | ||||
Sale and purchase of stock | ||||
Net borrowings | $6032.39 | |||
Total cash flows from financing | $35191 | $9274.05 | $2951.76 | $23276.87 |
Effect of exchange rate | -$572 | -$514.43 | $510.82 | $833.68 |
Change in cash and equivalents | $22350 | $7950.91 | -$1243.55 | -$3567.35 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | 1.31B |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | 0.00 |
Book/Share | 88.43 |
Cash/Share | 33.55 |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 0.25 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 2.82 |
Quick ratio | 2.81 |